Darusentan: a new perspective for treatment of resistant hypertension?

Author： Enseleit Frank   F Lüscher Thomas   Ruschitzka Frank  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.8, 2008-08, pp. : 1255-1263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduction of blood pressure in patients with treatment-resistant hypertension

By Acelajado Maria Czarina   Calhoun David A   Oparil Suzanne  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 2959-2971

Informa Healthcare

Access to resources Recommend Favorite

New drug targets for resistant hypertension look promising

By  

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

New Developments in the Diagnosis and Management of Resistant Hypertension

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1210-1218

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment resistant schizophrenia: new insights into neurobiology and treatment

By Weinberger D.R.   Lipska B.K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 201-201

Elsevier

Access to resources Recommend Favorite

New Insights in the Treatment Strategy for Pulmonary Arterial Hypertension

By Sahara Makoto   Takahashi Toshiyuki   Imai Yasushi   Nakajima Toshiaki   Yao Atsushi   Morita Toshihiro   Hirata Yasunobu   Nagai Ryozo  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 377-386

Springer Publishing Company

Access to resources Recommend Favorite